tirzepatide capsules Tablets: Safety, Risks & FDA Approval Status The dual Is Oral Tirzepatide Effective? The

FDA has raised specific concerns about compounded GLP-1 products: Reports of adverse events (including hospitalizations) tied to dosing errors with compounded injectable semaglutide Concerns about the use of semaglutide salt forms (sodium/acetate) rather than the base form used in FDA-approved products FDA has stated it is not aware of a lawful basis for compounding using these different salt forms Broader concerns about compounded GLP-1 dosing and titration beyond labeled dosing protocols Important distinction : Compounded medications prepared by state-licensed pharmacies operating under federal and state compounding frameworks are different from illegally marketed or counterfeit products sold online without valid prescriptions

Mutchler, S

Balancing the scales: Towards a more objective measure of sex differences in health

Heyboer M et al